Zydus Lifesciences Concludes USFDA Inspection at UK LiqMeds Facility with Four Observations
Zydus Lifesciences Ltd 路 Press Release 路 14 Nov 2026, 4:54 pm
Zydus Lifesciences Concludes USFDA Inspection at UK LiqMeds Facility with Four Observations The USFDA conducted an inspection at Zydus Lifesciences' LiqMeds facility in the UK from 9th Nov'26 to 13th Nov'26. The regulatory audit concluded with 4 observations. The company stated that it will work closely with the USFDA to address all observations expeditiously.
Original exchange filing (PDF)
More announcements from Zydus Lifesciences Ltd
- Completion of transaction 路 12 Nov 2026
- Transcript of the post results earnings call held on November 4, 2026. 路 07 Nov 2026
- Press Release 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India 路 06 Nov 2026
- Investor Conference 路 06 Nov 2026
- Audio recording of the Company's Investor Call 路 05 Nov 2026
- Press Release 路 04 Nov 2026
- Investor presentation 路 04 Nov 2026
